SCHEMBL8406237

SCHEMBL8406237

CCCCCCCC/C=C\CCCCCCCC(NC(CCCCCCC/C=C\CCCCCCCC)C(C)O)C(C)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.45
FFAR4 Q5NUL3 1/20 0.45
DEGS1 O15121 1/20 0.44
CETP P11597 1/20 0.44
FAAH O00519 4/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TRPV1 Q8NER1 1/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
KMT2A Q03164 1/20 0.42
TERT O14746 2/20 0.42
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11216600 0.89 SPHK1 (0.48) FFAR1FFAR4CETPKDM4EMEN1
SCHEMBL9718526 0.89 SPHK1 (0.48) FFAR1FFAR4CETPKDM4EMEN1
SCHEMBL8464498 0.83 DEGS1 (0.46) DEGS1CETPKDM4EALDH1A1MEN1
SCHEMBL4018634 0.79 FFAR1 (0.49) FFAR1FFAR4FAAHTRPV1MEN1
SCHEMBL29779670 0.79 SPHK1 (0.53) FFAR1FFAR4CETPFAAHKDM4E
SCHEMBL11748452 0.79 FAAH (0.53) FFAR1FFAR4FAAHKDM4EALDH1A1
SCHEMBL15304160 0.79 FAAH (0.53) FFAR1FFAR4FAAHKDM4EALDH1A1
SCHEMBL14371262 0.79 FAAH (0.53) FFAR1FFAR4FAAHKDM4EALDH1A1
SCHEMBL13691741 0.79 FAAH (0.53) FFAR1FFAR4FAAHKDM4EALDH1A1
SCHEMBL11753489 0.79 FAAH (0.53) FFAR1FFAR4FAAHKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240180808-A1 COSMETIC BASE AND COSMETIC COMPRISING PHOSPHORYLCHOLINE-LIKE GROUP-CONTAINING COMPOUND NOF CORPORATION (JP) 2024-06-06 US disclosed
EP-4316458-A1 COSMETIC BASE AND COSMETIC COMPRISING PHOSPHORYLCHOLINE-LIKE GROUP-CONTAINING COMPOUND NOF Corporation (JP) 2024-02-07 EP disclosed
EP-0612613-B1 Biaxially oriented multilayered polypropylene film, process of preparation and use thereof HOECHST TRESPAPHAN GMBH (DE) 1999-10-20 EP disclosed
EP-0623463-B1 Opaque, sealable, biaxially oriented polypropylene multilayered film, process for its manufacture and its use HOECHST TRESPAPHAN GMBH (DE) 1999-07-07 EP disclosed
EP-0623463-A1 Opaque, sealable, biaxially oriented polypropylene multilayered film, process for its manufacture and its use HOECHST AKTIENGESELLSCHAFT (DE) 1994-11-09 EP disclosed
EP-0612613-A1 Biaxially oriented multilayered polypropylene film, process of preparation and use thereof HOECHST AKTIENGESELLSCHAFT (DE) 1994-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240180808-A1 COSMETIC BASE AND COSMETIC COMPRISING PHOSPHORYLCHOLINE-LIKE GROUP-CONTAINING COMPOUND PHOSPHO1, SGMS1, H1-0 FFAR1 238/4885FFAR4 885/4885DEGS1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.